UnitedHealth Group (UNH) Stock Forecast & Price Target

$309.77 +7.48 (+2.48%)

Closing price 08/29/2025 03:59 PM Eastern

Extended Trading

$308.97 -0.80 (-0.26%)

As of 08/29/2025 08:00 PM Eastern

Compare

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Moderate Buy

Based on 24 Analyst Ratings

Sell
3

Hold
6

Buy
15

Based on 24 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 24 analysts, 3 have given a sell rating, 6 have given a hold rating, and 15 have given a buy rating for UNH.

Consensus Price Target

$353.00
13.95% Upside

According to the 24 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $353.00. The highest price target for UNH is $675.00, while the lowest price target for UNH is $198.00. The average price target represents a forecasted upside of 13.95% from the current price of $309.77.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for UNH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UNH Analyst Ratings Over Time

Type	Current Forecast 8/31/24 to 8/31/25	1 Month Ago 8/1/24 to 8/1/25	3 Months Ago 6/2/24 to 6/2/25	1 Year Ago 9/1/23 to 8/31/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	15 Buy rating(s)	15 Buy rating(s)	17 Buy rating(s)	18 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	1 Hold rating(s)
Sell	3 Sell rating(s)	3 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$353.00	$373.52	$439.17	$614.17
Forecasted Upside	13.95% Upside	57.34% Upside	44.34% Upside	4.06% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UnitedHealth Group Stock vs. The Competition

Type	UnitedHealth Group	Medical Companies	S&P 500
Consensus Rating Score	2.50	2.78	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	13.95% Upside	15,803.65% Upside	10.22% Upside
News Sentiment Rating	Positive News See Recent UNH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/26/2025	Cantor Fitzgerald 4 of 5 stars	Sarah James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$440.00	+44.13%
8/20/2025	Morgan Stanley 3 of 5 stars	Ricky Goldwasser Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$342.00 ➝ $325.00	+8.62%
8/18/2025	Bank of America 4 of 5 stars	Kevin Fischbeck Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$290.00 ➝ $325.00	+6.90%
8/6/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$418.00 ➝ $310.00	+26.23%
8/4/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$306.00 ➝ $267.00	+11.19%
7/31/2025	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Hold ➝ Strong Sell
7/31/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Underperform	$312.00 ➝ $198.00	-25.68%
7/30/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$355.00 ➝ $286.00	+9.65%
7/30/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$353.00 ➝ $317.00	+21.52%
7/30/2025	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Gillmor Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$400.00 ➝ $350.00	+34.01%
Get the Latest News and Ratings for UNH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.
7/30/2025	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$400.00 ➝ $325.00	+24.59%
7/17/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight
7/17/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy
7/16/2025	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	David MacDonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$360.00 ➝ $345.00	+17.81%
5/21/2025	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Herholdt Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Moderate Sell
5/21/2025	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sidharth Sahoo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Reduce	$490.00 ➝ $270.00	-16.09%
5/20/2025	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Justin Lake Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$501.00 ➝ $390.00	+21.90%
5/19/2025	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$520.00 ➝ $308.00	-1.39%
5/19/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Langston Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$308.00	+5.75%
5/16/2025	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$515.00 ➝ $350.00	+21.81%
5/14/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	George Hill Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$521.00 ➝ $362.00	+16.14%
5/14/2025	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ransom Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Market Perform
4/30/2025	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Engel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
4/21/2025	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Toung Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
12/5/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$605.00 ➝ $675.00	+10.54%
7/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$481.00 ➝ $647.00	+17.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 04:18 PM ET.

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, August 29, 2025. Please send any questions or comments about these UnitedHealth Group pros and cons to contact@marketbeat.com.

UnitedHealth Group
Bull Case

Here are some ways that investors could benefit from investing in UnitedHealth Group:

The company has demonstrated strong revenue growth, with a notable increase of approximately 12.9% compared to the same quarter last year, indicating robust business performance.
UnitedHealth Group has a solid return on equity of over 23%, reflecting effective management and the ability to generate profits from shareholders' equity.
The current stock price is around $350, which may present a buying opportunity for investors looking to enter at a favorable valuation.
With a dividend yield of approximately 2.9% and a payout ratio of 38.3%, investors can expect a steady income stream from dividends, which is appealing for income-focused investors.
Analysts have a consensus rating of "Moderate Buy" for the stock, with many recent reports suggesting potential for price appreciation, which could benefit investors in the long run.

UnitedHealth Group
Bear Case

Investors should be bearish about investing in UnitedHealth Group for these reasons:

The company recently reported earnings per share (EPS) of $4.08, which fell short of analysts' expectations of $4.45, indicating potential challenges in meeting future earnings targets.
There has been a downward revision in price targets by several analysts, suggesting a cautious outlook on the stock's near-term performance.
UnitedHealth Group's net margin is around 5%, which may raise concerns about profitability compared to industry peers, potentially affecting investor confidence.
Insider selling activity, such as the CEO selling shares, could signal a lack of confidence in the stock's short-term prospects, which may deter some investors.
With a significant portion of analysts rating the stock as "Hold" or "Sell," there may be mixed sentiments in the market, leading to uncertainty for potential investors.

UNH Forecast - Frequently Asked Questions

: According to the research reports of 24 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $353.00, with a high forecast of $675.00 and a low forecast of $198.00.
: 24 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last twelve months. There are currently 3 sell ratings, 6 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" UNH shares.
: According to analysts, UnitedHealth Group's stock has a predicted upside of 13.95% based on their 12-month stock forecasts.
: Over the previous 90 days, UnitedHealth Group's stock had 3 downgrades by analysts.
: UnitedHealth Group has been rated by research analysts at Baird R W, Bank of America, Barclays, Cantor Fitzgerald, JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Oppenheimer, Piper Sandler, Robert W. Baird, Royal Bank Of Canada, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like UnitedHealth Group less than other "medical" companies. The consensus rating score for UnitedHealth Group is 2.50 while the average consensus rating score for "medical" companies is 2.78. Learn more on how UNH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:UNH) was last updated on 8/31/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UnitedHealth Group (UNH) Stock Forecast & Price Target